Le Lézard
Classified in: Health
Subjects: MAV, CMG

/R E P E A T -- Media Advisory - City of Toronto to host technical briefing on new mental health and substance use strategy/


TORONTO, Nov. 19, 2023 /CNW/ - The City of Toronto will hold a technical briefing on Monday, November 20, to introduce media to "Our Health, Our City: A Mental Health, Substance Use, Harm Reduction and Treatment Strategy for Toronto." Toronto's Medical Officer of Health, Dr. Eileen de Villa, Uppala Chandrasekera, Director, Public Health, and Dr. Shovita Padhi, Associate Medical Officer of Health will provide an overview of the strategy to media.

Following the technical media briefing, an in-person launch event will be held at Toronto City Hall that will be attended by Deputy Mayor Ausma Malik (Spadina-Fort York) and Chair of the Board of Health, Councillor Chris Moise (Toronto Centre).  

Date:

Monday, November 20

Time:

8:30 a.m. (Technical briefing ? online only). Registration details below.
9:15 a.m. (Media availability).City Hall, 100 Queen St. W., A-Street Reception

Media can register for the technical media briefing here:
https://toronto.webex.com/weblink/register/rabf59d52af08d0cf1185ebbbe8be9e7b 

Note: Media will be provided access to the presentation deck and strategy document 30 minutes prior to the technical briefing.

Toronto is home to more than three million people whose diversity and experiences make this great city Canada's leading economic engine and one of the world's most diverse and livable cities. As the fourth largest city in North America, Toronto is a global leader in technology, finance, film, music, culture, innovation and climate action, and consistently places at the top of international rankings due to investments championed by its government, residents and businesses. For more information visit www.toronto.ca or follow us on Twitter at www.twitter.com/CityofToronto, on Instagram at www.instagram.com/cityofto or on Facebook at www.facebook.com/cityofto

SOURCE Toronto Public Health


These press releases may also interest you

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 07:00
Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of two posters on TERLIVAZ® (terlipressin) for injection in patients with hepatorenal syndrome (HRS) with rapid reduction in kidney function1 at the 2024...

17 mai 2024
Family Braces, Calgary's largest group of orthodontists with five locations across the city, reports a strong start to the second quarter of 2024. This positive momentum builds on the group's successful first quarter, underlining its...

17 mai 2024
American Skin Association (ASA) announced the recipients of the 2024 Inaugural Founders Award and the 2024 Research Achievement Awards at the 2024 Society for Investigative Dermatology (SID) Annual Meeting. ...



News published on and distributed by: